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Abstract: In 2015 Zika virus (ZIKV) emerged for the first time in South America. The following ZIKV
epidemic resulted in the appearance of a clinical phenotype with microcephaly and other severe
malformations in newborns. So far, mechanisms of ZIKV induced damage to the fetus are not
completely understood. Previous data suggest that ZIKV may bypass the placenta to reach the fetus.
Thus, animal models for ZIKV infection are important to facilitate studies about ZIKV infection
during pregnancy. Here, we used ultrasound based imaging (USI) to characterize ZIKV induced
pathogenesis in the pregnant Type I interferon receptor-deficient (IFNAR-/-) mouse model. Based on
USI we suggest the placenta to be a primary target organ of ZIKV infection enabling ZIKV spreading
to the fetus. Moreover, in addition to direct infection of the fetus, the placental ZIKV infection may
cause an indirect damage to the fetus through reduced uteroplacental perfusion leading to intrauterine
growth retardation (IUGR) and fetal complications as early as embryonic day (ED) 12.5. Our data
confirmed the capability of USI to characterize ZIKV induced modifications in mouse fetuses. Data
from further studies using USI to monitor ZIKV infections will contribute to a better understanding
of ZIKV infection in pregnant IFNAR-/- mice.
Keywords: Zika virus; uteroplacental infection; viral pathogenesis; pregnancy; ultrasound
1. Introduction
ZIKV has been first identified in 1947 in a sentinel monkey in ZIKV forest in Africa. First confirmation
of ZIKV in humans has been obtained in 1952, when ZIKV was firstly isolated from a human suffering
from the so called Zika Fever [1]. Since then, sporadic ZIKV outbreaks have occurred in Africa and
Asia [2]. Another clinical outcome of ZIKV infection is the induction of the Guillain-Barré syndrome
manifesting in various neurological disorders through damaging the peripheral nervous system [3–6].
As a classical arbovirus, ZIKV is transmitted by mosquitos [7–9]. In addition, recent data confirmed
that ZIKV can be also spread through the sexual and vertical route [10–13] In 2015 the virus suddenly
emerged on the American continent causing an epidemic of congenital human abnormalities. During
the epidemic, ZIKV infection during pregnancy resulted in fetal abnormalities such as microcephaly,
neurological malfunction, and spontaneous abortion [11,14,15]. Of note, a significantly increased
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occurrence of the congenital ZIKV syndrome (CZS) has been observed in South America in Brazil,
Columbia and other countries, with diagnosis occurring in different geographical areas without
epidemiological connectivity. Interestingly, in a cohort study performed early during the Brazilian
ZIKV epidemic revealed that 42% of the fetuses developed CZS independent of the trimester of
infection in a cohort of 182 ZIKV-infected and symptomatic pregnant women [14]. In human fetal
studies brain imaging findings have been undertaken using magnetic resonance imaging (MRI) and
fetal ultrasound [16–18]. The major clinical findings during the pregnancy included ventriculomegaly
in the cerebrum, hypoplasia of the cerebellum, calcifications and myelination defects resulting in
different malformations [19,20]. Moreover, after birth CZS is characterized by significant damage
of the sensorineurological outcomes including hearing loss and significant ocular defects [21–24].
However, we still know relatively little about the specific pathological mechanism underlying CZS [25].
Preliminary insights into the molecular mechanism of ZIKV infection within fetuses came from studies
using in vitro cultures of different neuronal progenitor cells and brain cells [26]. Here, ZIKV infection
of progenitor cells of the cerebral cortex increased inflammation and cell death resulting in reduced
cell proliferation. Moreover, ZIKV infection of astrocytes induced the modulation of the specific
immune responses that suppresses the cell surface protein Axl [27,28]. Another mechanism of ZIKV
induced feto-pathogenesis as identified in an infection model of brain slices in vitro generated from
embryonic mice of various ages showed that ZIKV replication in the neocortical proliferative zone and
in the developing midbrain induced apoptosis, which may limit viral dissemination in the brain and
may constrain virus-associated injury [29]. In addition, the placenta is an important target organ of
mother to fetus derived ZIKV infection. Here, in vitro evaluation of placental cell organoids revealed
that human trophoblast isolated early during pregnancy propagated ZIKV to very high titers [30,31].
In contrast, ZIKV infection of human trophoblast derived from later pregnancy stages demonstrated less
efficient ZIKV amplification compared to the early pregnancy [32]. This result may further support the
hypothesis of reduced susceptibility of fetal ZIKV infection in later stages of pregnancy [33]. Currently,
it is not understood how likely ZIKV infection during pregnancy results in infection and damage to
the fetus. So far, the first trimester of human pregnancy is considered as the time period in which the
fetuses are most vulnerable to ZIKV infection and the development CZS [34–36]. After confirmed or
possible ZIKV infections in pregnant women, the Center for Disease Control and Prevention (CDC)
recommends repeated fetal ultrasound to monitor for possible fetal malformation especially in the head
regions. For humans, fetal ultrasound is well established and easy to interpret due to a wide range
of technical features and support. However, with the progression of the American ZIKV epidemic,
the incidence of ZIKV infection in pregnant women is also declining, before a detailed understanding
of CZS has been accomplished. Therefore, animal models of ZIKV infection are important and
essential to better understand the mechanisms and causes of CZS. Non-human primates have been
established as a model for maternal ZIKV infection during pregnancy. In that context, Hirsch and
coworkers already successfully used non-invasive ultrasound (US) throughout pregnancy to evaluate
fetal growth, uteroplacental blood flow and amniotic fluid index [37]. The mice lacking the interferon
alpha/beta receptor (IFNAR-/-) provide a promising preclinical model of congenital ZIKV infection.
Here, challenge infection on embryonic day 7.5 (ED 7.5) results in fetal abnormalities resembling
the intrauterine growth restriction and spontaneous abortion observed in ZIKV-infected pregnant
women. For this, the development of fetal ultrasound diagnostic tools might be advantageous to better
understand the pathogenesis of CZS in an early stage of mouse pregnancy. In addition, this approach
would be helpful to test new therapies and vaccines that could prevent or mitigate the intrauterine
ZIKV infection. Here, we characterized the outcome of ZIKV infection in pregnant IFNAR-/- mice
using ultrasound imaging (USI). We confirmed the occurrence of ZIKV induced malformations and
damage to fetuses on ED 13.5. Interestingly, modifications in the placenta, a major target organ of
ZIKV infection, were not clearly visible by USI before ED 14.5. As the first sign of ZIKV induced
pathogenesis we detected evidence of disturbed blood circulation in the uteroplacental vessels as early
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as ED 12.5 supporting the hypothesis of hypoxia induced damage to fetuses. These results support the
future use of USI to better characterize ZIKV pathogenesis in pregnant IFNAR-/- mice.
2. Materials and Methods
2.1. Study Design
Female 6-10-week-old IFNAR -/- mice were mated in a 1:1 scheme for 24 h. Successful mating was
observed by plug check on the following day. Plug positive mice were then separated and examined
via ultrasound starting on embryonic day (ED) 4.5 which is the first timepoint for reliable confirmation
of pregnancy. Signs of illness, weight loss, and survival were monitored daily. In two independent
experiments mice (n = 10) were infected on ED 7.5 with a total dose of 103 plaque-forming-units
(PFU) of Zika virus strain H/PF/2013 (EVAg, clinical isolate, French Polynesia 2013, GenBank Sequence
Accession: KJ776791) diluted in 50µl physiological saline via footpad infection in the left hind leg.
Control mice (n = 8) were mock-infected with saline (PBS).
On ED 16.5 mice were euthanized and fetuses (n = 7 0), placentas (n = 7 0) and selected maternal
organs (brain, spinal cord, uterus, and ovaries) were harvested, weighed and documented. After fixation
of samples with paraformaldehyde for histopathology, remaining organ material was stored at −80 ◦C
for titration of infectious virus.
2.2. Mice
IFNAR-/- mice [38] backcrossed more than 20-fold on the C57BL/6 background were bred
under specified-pathogen-free (SPF) conditions, housed in isolated cage units (IsoCage, Tecniplast,
Hohenpeißenberg, Germany) and had access to food and water ad libitum. All experiments were
approved by the Government of Upper Bavaria, Munich Germany and were performed in compliance
with the German Animal Welfare Act.
2.3. Cells and Viruses
Vero (African green monkey kidney) cells (ATCC CCL-81) were used. Plaque-purified Zika virus
(ZIKV) Isolate H/PF/2013 (EVAg, clinical isolate, French Polynesia 2013, GenBank Sequence Accession:
KJ776791) was propagated on Vero cells. Viral titers were determined by plaque assay and titrated,
with values reported in PFU as previously described [39].
2.4. Ultrasound Imaging
For ultrasonographic examination we used the ultrasound system MyLab™Delta (Esaote, Genoa,
Italy) with a linear array 20 MHz transducer (SL3116, Esaote, Genoa, Italy). We chose an ultrasound
system that is routinely used in veterinary medicine for multiple approaches. Unanesthetized pregnant
mice were exposed to B-Mode, 20MHz, pulsed USW and a scanning rate of 35 frames per second for
2-3– min in different schedules dependent on total duration and pregnancy time points (Figure 1).
Approximately 1 cm3 prewarmed Aquasonic ultrasound gel (Parker, Fairfield, NJ 07004 USA) was
placed between the transducer face and the abdomen of the mouse. Mice were scanned from caudal to
cranial. In doing so, we positioned the bladder and the uterus including the specific position of the
fetuses. We used the standard ultrasound examination to assess the morphology and size of the fetuses
and the placenta. In addition, standard Doppler ultrasound measurements evaluating uteroplacental
hemodynamics were performed by using the MyLab™Delta as described before [40]. Color Doppler
ultrasound complements the ultrasonic B-mode examination and enables the assessment of perfusion
and circulation. Color Doppler ultrasound can be used to demonstrate the presence or the reduction of
blood flow and its direction. Signals are reported and visualized via blue or red signals. Blood flow
activity was measured by using the mean of the score of pulsation in brain vessel or umbilical cord
diameter and the score of the percentage of living fetuses (see Table 1 below). Fetal heart rate was
quantified by manually counting fetal heart contractions and so resulting Doppler USI signal.
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Table 1. Scoring sheet for characterization of blood flow activity in the umbilical cord and the fetal brain.
(a)
Pulsating Umbilical Cord Diameter
Score “a” ED 11.5 ED 12.5 ED 13.5 ED 14.5 ED 15.5 ED 16.5
3 >0.5 mm >0.5 mm >0.6 mm >0.6 mm >0.7 mm >0.8 mm
2 <0.5 mm <0.5 mm <0.6 mm <0.6 mm <0.7 mm <0.8 mm
1 <0.3 mm <0.3 mm <0.4 mm <0.4 mm <0.5 mm <0.5 mm
0 Neg. Neg. Neg. Neg. Neg. Neg.
(b)
brain vessel diameter
Score “b” ED 12.5 ED 13.5 ED 14.5 ED 15.5 ED 16.5
3 >0.05 mm >0.05 mm >0.05 mm >0.08 mm >0.08 mm
2 <0.05 mm <0.05 mm <0.05 mm <0.08 mm <0.08 mm
1 <0.03 mm <0.03 mm <0.03 mm <0.05 mm <0.05 mm
0 Neg. Neg. Neg. Neg. Neg.
(c)
Score “c” % living fetuses
3 >80%
2 <80%
1 <50%
0 <25%
Scoring: umbilical cord blood flow activity = (Score “a” + Score “c”) / 2; fetal brain blood flow activity = (Score “b”
+ Score “c”)/2.
2.5. Determination of ZIKV Loads in Mouse Organs
Organs (brain, spinal cord, ovaries, uterus, placenta, embryonic head) were removed under aseptic
conditions from sacrificed mice (n = 8–10). The organs were immediately frozen and subsequently
thawed, weighed, and homogenized using 0,1 g of organ material with 1 ml PBS in a microtube
(Retsch Tissue Lyser MM300, Qiagen GmbH, Hilden, Germany). Tubes were centrifuged for 1 min at
1.500 rpm and 4 ◦C. Supernatants were taken and stored at −80 ◦C. Viral titers in organ supernatants
were determined by plaque assay as described before [39] and indicated in PFU per 1 g organ material.
2.6. Histopathology and Immunohistochemistry
Placentas of sacrificed mice were routinely fixed in paraformaldehyde for 24 h and subsequently
embedded in paraffin. Sections of 4 µm were stained with hematoxylin and eosin (HE) before being
evaluated by light microscopy. Primary antibody for immunohistochemistry (IHC) was a rabbit
anti-Flavi-E diluted (1:1000, absolute antibody, Ab00230-23.0, Oxford, UK). Placentas of PBS-inoculated
mice served as negative controls. After deparaffinization, sections were blocked with hydrogen
peroxide followed by diluted normal goat serum (30 min). Primary antibody incubation was done
for 60 min at room temperature. Biotinylated secondary antibody was a goat-anti-rabbit antibody
(1:200, Vector, BA-1000, Burlingame, CA, USA). Peroxidase-complexed avidin-biotin (ABC-HRP, Vector,
PK-6100) and diaminobenzidine (DAB) were used for visualization and hemalaun as counterstain.
Control experiments were performed by using chimeric rabbit IgG (abcam, AB172730, Cambridge, UK)
as negative control and primary antibody on a mixed cell culture of ZIKV-infected and non-infected
Vero cells. Von Kossa staining was used to detect and to quantify mineralization in placental samples.
Images were taken by a Keyence microscope (Keyence BZ-X700, Keyence, Neu-Isenburg, Germany).
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2.7. Statistical Analysis
All data were analyzed with GraphPad Prism version 5.0 (GraphPad Software Inc, San Diego CA,
USA) and MedCalc software (MedCalc Software, Ostend, Belgium). Data were expressed as mean ±
standard error of the mean (SEM) and as medians and the interquartile range (IQR) of the median.
Statistical analysis to compare two groups was performed using the Mann–Whitney test, the unpaired,
two-tailed t-test after calculation of the area under the curve and the Shapiro–Wilk test for normal
distribution. The threshold for statistical significance was p < 0.05.
3. Results
3.1. Outcome of ZIKV Infection in Pregnant IFNAR-/- Mice as Analyzed by Sonography
To confirm pregnancy after positive plug-check, mice were examined on estimated ED 4.5 by
ultrasound imaging (USI). Here sectional views (Figure 1, A+B, ED 4.5) showed substantial proliferation
of both uterus horns (“U”) as seen in increased diameter relative to the bladder (“B”, shown in black).
This increase is accompanied by proliferation of the mucosa as seen by higher echogenicity (image
brightness in USI) on the sectional plane of the uterus. These observations confirmed the successful
implantation process and mice that met these anatomical criteria as visualized by USI were considered
positive pregnant and were included in this study.
These mice were analyzed by USI every day and representative images are shown in Figure 1 for
EDs 4.5, 9.5, 13.5, 14.5, and 16.5. On ED 7.5 pregnant mice were either infected with ZIKV or with PBS
as mock control. Two days after the challenge infection (ED 9.5) we observed continued growth of
ampoules in both uterus horns, as seen by an average diameter of 2.8 mm for the PBS mock-infected
mice (Figure 1 A, ED 9.5, “U1/2”, “B”, the bladder in black, Figure 1C) and an average in diameter of
2.6 mm in the ZIKV-infected mice (Figure 1B, ED 9.5, “U”, transverse sections in relative position to the
bladder “B”, in black, Figure 1C). Of note, compared to the earlier embryonic stages as analyzed before,
we succeeded in the imaging of two different sections through the uterus horn ampoules indicating
an ongoing growth activity of physiological pregnancy for both experimental groups. These results
indicate no obvious differences between PBS mock-infected mice and ZIKV-infected mice. On ED
13.5 USI identified a significant increase in the size of the uterus with a diameter of 7 mm in the
mock-infected control group (Figure 1A, ED 13.5, Figure 1C). Of note bladder was not included in
the picture using comparable insonation-angle (kept < 20◦) supporting this observation. In addition,
we were able to visualize highly echogenic structures (in USI brighter shades of grey) within the less
echogenic (in USI darker shades of grey) liquid filled lumens of the uterus indicating a developing
fetus (“F” in Figure 1A, ED 13.5).
A slightly brighter echogenic structure associated with the fetus suggested the starting formation
of the first vessel structures. Under the tentative fetal structure another highly echogenic structure was
visible that was identified as placental tissue (“P”, framed by white crosses). In ZIKV-infected animals
we observed different uterus sections with a mean diameter of 5.5 mm indicating reduced fetal and
placental development compared to the mock-infected control mice on ED 13.5 (Figure 1B, ED 13.5,
Figure 1C). In addition, hypoechogenic structures within the uterus lumen demonstrated the presence
of free liquids. Free liquids, identified as highly echogenic structures were also clearly detectable
within the uterus lumen representing embryonic residues. Of note, bladder (“B”, black) still appeared
in the USI while using the specific USI insonation-angle as established before. Another prevalent
echogenic crescent-formed structure was visible on ED 13.5 in the ZIKV-infected mice showing the
developing placental tissues (framed by white crosses).
On ED 14.5 USI in the PBS mock-infected group revealed the development of the ampoules
with an average of 8 mm in diameter, corroborating the physiologic course of pregnancy (Figure 1C).
This observation was further confirmed by transverse sections through the uterus horn lumens. Here,
the specific echogenic structures strengthened the detection of a growing fetus (“F” in Figure 1A, ED
14.5), as identified by prominent anatomical structures, the fetal head (“FH”) and fetal limbs. Moreover,
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on ED 14.5 the specific vessel structure, first seen on ED 13.5, showed further consolidation and was
identified as the umbilical vein (“Uc”), connecting the fetus to the mother. In line with this observation,
we could also detect the consolidation of the placental tissue (“P”, framed by white crosses).
In contrast, in the ZIKV-infected group on ED 14.5, transverse sections through the uterus horn
revealed a lumen-diameter of 6 mm in average, showing the same pattern as seen on ED 13.5 and 9.5
(Figure 1B, ED 14.5, Figure 1C). Of note, the size of the uterus ampoules as analyzed by USI, was smaller
compared to the mock control group with 8mm in size (Figure 1C). When we performed USI through
the ampoules an undefined bright echogenic structure was visualized, indicating resorbed fetal debris
(“FR”). Further detailed screening through the uterine ampoules also indicated the presence of free
liquid as visualized by less echogenicity. In the majority of ampoules, no vessel-like structure was
detectable by USI. While we did not detect many consolidated fetal structures in the ZIKV-infected
mice, we were able to visualize the placental tissue adjacent to the resorbed fetal debris or in the liquid
filled sections visible as hyperechogenic area (“P”, framed by white crosses).
In the mock-infected group, after 16 days of gestation, on ED 16.5, uterus horns could be visualized
as massive anatomical structures in the USI with a mean diameter of 9.5 mm (Figure 1A, ED 16.5,
Figure 1C). Transversal sections analyzing the uterus ampoules revealed a further matured fetus (“F”),
as identified by defined organic structures with the highly echogenic foci identified as the fetal heart
(“FC”) and the fetal paws as visualized with high echogenicity (“FP”). In addition, we could detect
fully formed umbilical veins (Figure 1A, ED 16.5) connected to the associated crescent shaped placentas
with bright echogenicity (“P”, framed by white crosses) lining the uterus walls.
On ED 16.5 the uterus ampoules displayed a mean of 6mm in ZIKV-infected mice (Figure 1C).
In addition, we detected comparable echogenic structures indicating resorbed fetal residues as seen in
prior USI (“FR”) including the placentas with brighter echogenicity (“P”, framed by white crosses) and
inner side of the uterus next to a uterus lumen with less echogenic foci (“L”, in black) implying a liquid
filling (Figure 1B, ED 16.5).
To exclude that mortality of the fetuses was due to the multiple handling of pregnant dams, we
comparatively summarized these USI surveyed data establishing time kinetics after ZIKV challenge
infection. In consequence, we observed significantly higher rates of fetal mortality in the ZIKV-infected
group compared to mock-infected mice (Figure 1D). Moreover, the ZIKV-infected dams showed early
signs of dead or resorbed fetuses on ED 10.5 accounting for 20% of the fetuses monitored. Subsequently,
numbers of spontaneous abortion or intrauterine deaths increased over the following days resulting
in almost 100% mortality on ED 16.5. However, in the PBS mock-infected group, first signs of fetal
mortality were detected on ED 11.5, which constituted to 5% in the fetuses analyzed. Until ED 16.5 no
increase in fetal mortality was observed confirming the ZIKV induced mortality in the fetuses.
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ext to the bladder (“B”, shown in black) on ED 4.5.; ED 9.5: (A) + (B) Echogenic foci of the uterus horns
are prominent on ED 9.5.; ED 13.5: (A) the placenta and the developing fetuses are visible (“P”, framed
by white crosses, “F”) and the umbilical cord (“Uc”), (B) the placenta is visible in the uterus lumen (“P”,
framed by white crosses, “L”, shown in black) and indistinguishable fetal structures (“FR”); ED 14.5:
(A) growing fetus (“F”), with distinct structures such as the fetal head (“FH”), the umbilical cord (“Uc”)
and the placenta (“P”, framed with white os es) on ED 14.5, (B) the uterus lumen is either filled with
fetal residues including the placentas (“FR”, “P”, framed ith white crosses) or empty on ED 14.5; ED
16.5: (A) highly developed fetus with distinguishable fetal thorax, the fetal heart and paws (“F”, “FC”,
“FP”) and the placenta (“P”, framed with white crosses) on ED 16.5, (B) Uterus lumen (“L”, shown
in black) including placentas with unclear fetal residuals on ED 16.5; (C) Analysis of uterus diameter
using USI at different timepoints during pregnancy (n = 8- 10dams per group, graph represents 2–3
independent measurements per uterus). Differences between individu l groups wer analyzed by
Mann–Whitney test. Error bars indicate the interquartile range (IQR) from the median. Asterisks
represent statistically significant differences between two groups: ns = non-significant, *** p = 0.0002;
(D) Tabular summary of the ultrasound based findings as identified in (A,B) in the mock-infected mice
(n = 20 fetuses, 4 examined fetuses/uterus ampoules per mouse and timepoint); (E) Tabular summary
of the ultrasound based findings as identified in (A,B) in the Zika virus (ZIKV)-infected mice (n = 20
fetuses, 4 xamined fetu es/uterus ampoules per mouse and timepoint).
3.2. Evaluation of Uteroplacental Blood Flow Activity by Doppler Ultrasound
Direct Comparison between ED 13.5 and ED 16.5
Since the data so far confirmed intrauterine growth retardation (IUGR) and fetal death in
ZIKV-infected pregnant IFNAR-/- mice, we aimed to evaluate the ZIKV influence on the physiological
parameters of the fetuses. For this we infected IFNAR-/- mice on ED 7.5 with ZIKV or with PBS as
control and comparatively monitored the fetal heart rate in the ZIKV-infected and PBS control group
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starting on ED 11.5 (Figure 2A). In the PBS mock-infected group, fetal heart rate started with a mean of
145 bpm on ED 11.5 and did not significantly change until ED 14.5, showing a slight upward trend to
150 bpm (referring to mean fetal heart rate). Between ED 11.5 to ED 16.5 fetal heart rate increased to
a mean of 200 bpm, corresponding to the expected physiological value [41]. ZIKV infection did not
result in significantly different heart rate values (mean = 150 bpm on ED 11.5). However, it seemed
that fetuses from the ZIKV-infected group showed a more distinctive increase of the heart rate between
ED 11.5 and ED 14.5 indicating a mild type of fetal tachycardia. Interestingly, on ED 15.5 the fetal
heart rate significantly decreased in the ZIKV-infected mice resulting in 140 bpm and on ED 16,5
fetuses only showed a rate of 50 bpm. From these data we concluded that ZIKV infection inadvertently
influences the fetal circulatory system. However, since perceptible deviations on fetal heart rates
were not identified before ED 15.5, we aimed also to comparatively monitor the blood flow activity
in the uteroplacental vessels, which are essential for transfer of nutrients between mother and fetus
(Figure 2B–D). To enable a standardized characterization of the blood flow activity pattern, we used
the highly echogenic placenta as starting point to perform Doppler-US. Starting on ED 7.5, doppler
ultrasonographic examination of uteroplacental circulation revealed evolving blood flow activity
in the umbilical vessels. Of note, there was no obvious difference between the ZIKV-infected and
mock-infected control mice until ED 13.5. We detected dynamic blood flow activity in the PBS control
mice when analyzed on ED 13.5 as shown by the Color Doppler USI (Figure 2C). Doppler USI signals
indicated productive recirculation of maternal blood to the fetus. Measurement of uterine artery
diameter showed a mean of 0.85 mm. This is further confirmed on ED 16.5 when we detected umbilical
and fetal blood vessels in comparable position. Color Doppler USI indicated that the vessel diameter
was further dilated with a mean diameter of 0.93 mm. Moreover, the intensity of the signals was in line
with a physiological proceeding of the pregnancy. When we performed Doppler USI in mice from the
ZIKV-infected group, we were again able to specifically detect productive blood flow activity in the
umbilical vessels adjacent to the placenta on ED 13.5 (Figure 2D). However, when measuring diameter
of the uterine artery, we determined a mean of 0.36 mm. This diameter was smaller than the diameter
in the mock control group. On ED 16.5 we again found the placenta to be a highly echogenic structure.
However, on ED 16.5 we failed to detect any blood flow activity as seen by the lack of blue and red
colored signals in Doppler USI. In detail, we did not observe any blood recirculation from the mother
to the fetus. Moreover, confirming previous results, USI revealed undefined structures with high
echogenicity indicating resorbed fetal tissue. When we summarized the data from Doppler USI, clear
differences in blood flow activity were detected in ZIKV-infected dams compared to mock-infected
control mice (Figure 2B). Interestingly, as early as ED 12.5 results from the Doppler USI allowed for the
identification of ZIKV induced pathogenesis.
Since ZIKV infection has been associated with cerebral anomalies including microcephaly, we also
assessed blood flow activity in the region of fetal head on ED 16.5 when USI allowed for differentiation
of fetal structures (Figure 2E,F). In PBS mock-infected animals, color Doppler USI identified a productive
blood circulation adjacent to the hyperechogenic fetal head (Figure 2E). Again, when we analyzed
the Doppler USI data on the vessel diameter over time, we detected significant differences in the
perfusion of fetal heads in the PBS and ZIKV-infected groups on ED 16.5 (Figure 2E). Fetuses from PBS
control dams revealed an effective blood flow activity that remained stable until end of the experiment
(Figure 2F). However, in the ZIKV group, fetuses showed lower perfusion rates in the heads as seen by
reduced vessel diameters (44% smaller compared to PBS) on ED 12.5. Over the following days the
blood flow activity in the fetal heads significantly decreased to 25% compared to the level observed
in the control group on ED 13.5 and no blood flow activity was detected on ED 14.5. These data
indicated that ZIKV induced pathology targeting the fetal head is much earlier detectable than in the
uteroplacental transfusion.
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Figure 2. Ultrasound based demonstration of fetal blood flow activity and heart rate measured by
Doppler ultrasound; (A) + (B) Pregnant interferon receptor-deficient (IFNAR-/-) mice were inoculated
with PBS (mock-infected animals, used as controls) or with 103 plaque-forming-units (PFU) ZIKV on
embryonic day 7.5 (ED 7.5). In all experiments, heart rates of individual fetuses were monitored daily
(n = 6-8– fetuses per group). Data are representative of two experiments. Here: Graphical summary
of the data obtained by Doppler measurements of uterine vessels blood flow activities (Figure 1A:
error bars indicate SEMs and differences between the groups were analyzed by unpaired, two tailed
t-test. Asterisks represent statistically significant differences between two groups; n = ns, ** p = 0.0012,
*** p = 0.0002, **** p < 0.0001, Figure 1B: error bars indicate SEMs and differences between the groups
were analyzed by two-tailed t-test after calculation of the area under the curve, **** p < 0.0001);
(C) + (D) Measurement of the utero-placental blood flow activity i th uterine vessels obtained
by Doppler-ultrasound on ED 13.5 and 16.5 for the PBS control mice a the ZIKV-infect d mice;
(E) Measurement of the blood flow activity in the fetal heads obtained by Doppler-ultrasound on ED
16.5 for th PBS control mice and he ZIKV-infec ed mice; (F) Graphical summary of the data obta ned by
Doppler measur ment of blood flow activities in the fetal heads (n = 6–8 fetuses per group); error bars
indic te SEMs and differences between the groups were analyzed by two-tailed t-test after calculation
of the area under the curve, **** p < 0.0001.
3.3. Characterization of ZIKV Infection of the Placenta
The placenta is considered as an important target organ for ZIKV i fection resulting in direct
transmission to the fetus [14,15]. Our USI data fr m p egnant mice demonstrated that the place a can
be detected as a clearly visible structure. To haracterize the influence of ZIKV nfection on the placental
Viruses 2020, 12, 72 11 of 19
functionality in more detail, we comparatively monitored shape, thickness, and texture of the placenta
in USI (Figure 3A). On ED 11.5, we observed no big differences in the placental thickness between
ZIKV-infected and control mice with a mean thickness of 1.8 mm and 2.0 mm, respectively. Direct
comparison in USI also indicated no obvious differences in the organ texture and density. However,
on ED 14.5, placental thickness in ZIKV-infected mice was significantly lower than in the mock-infected
control mice (Figure 3A,B). The mean thicknesses for the two groups were 1.96 mm and 2.82 mm
respectively (Figure 3B). In addition, USI revealed a modified appearance of the placental texture.
Placentas from ZIKV-infected mice were brighter compared to the placentas of PBS controls indicating a
higher echogenicity and echotexture. In contrast, the PBS infected placentas remained visible as a crescent
shape with light colored staining (Figure 3A). This data was confirmed by uteroplacental pathology
including histopathological analysis at the end of the experiment. Interestingly, the absolute placental
weight was significantly lower in ZIKV-infected mice compared to controls (Figure 3C). The mean
placental weight in the PBS control group was 0.125 g whereas placentas from ZIKV-infected mice had a
mean weight of 0.05 g only. Moreover, the histopathological examination also revealed features of ZIKV
infection in agreement with the differences in thickness and echogenicity determined by USI on ED 11.5.
Finally, when monitoring virus loads, we found large amounts of virus in the placentas of
ZIKV-infected mice corroborating their importance as target organ during in vivo infection (Figure 3D).
Placentas of ZIKV-infected mice showed extensive ZIKV-specific staining, primarily in areas of the
labyrinth zones severely affected by inflammation (Figure 3E). Several trophoblasts lines, like glycogen
trophoblasts, spongiotrophoblasts, and to a lesser extent cytotrophoblasts and syncytiotrophoblasts
showed antigen expression in a variable amount. Upon H&E staining, we detected large areas of
densely packed inflammatory cells, mainly comprising lymphocytes and scattered macrophage-like
cells as well as granulocytes in placentas from ZIKV-infected dams. Especially in the labyrinth
zone, there seemed to be irregular shaped fetal capillaries in decreased numbers. Interestingly, these
inflammatory processes seemed to be mainly associated in the labyrinth layer resulting in an obvious
thinning of the placenta compared to mock-infected control mice (Figure 3F). Since IHC confirmed a
direct ZIKV infection of placental cells, we aimed to correlate the reduced echogenicity in USI with
direct effects of ZIKV infection. Of note, we specifically detected the presence of placental calcifications
by Kossa-specific staining in the tissues from ZIKV-infected mice (Figure 3G). Interestingly these
calcifications were mainly seen in the labyrinth zones around smaller vessels and some were filled
with erythrocytes. Calcifications were visible in the basal labyrinth zone near the chorionic epithelium
of infected mice, whereas in the control group this was not visible.
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Figure 3. ZIKV induced changes in the placenta; (A) Measurement of placenta thickness by ultrasound
imaging. Representative images from ED 10.5, 11.5, 14.5, and 15.5 are depicted for PBS control mice
and ZIKV-infected mice; (B) Comparative evaluation of placental weights on ED 16.5 in sacrificed mice
(n = 8–10 mice per group; differences between individual groups were analyzed by Mann–Whitney
test. Error bars indicate the interquartile range (IQR) from the median. Asterisks represent statistically
significant differences between two groups: **** p < 0.0001; (C) ZIKV challenge of pregnant mice results
in highly productive ZIKV infection of placental tissues, virus titers in placentas after ZIKV infection.
At the end of the experiments (ED 16.5) placentas were removed and homogenized, and the amount of
virus was determined by plaque assays (n= 31–39 placentas per group); data are representative of at least
two independent experiments; differences between individual groups were analyzed by Mann–Whitney
test. Error bars indicate the interquartile range (IQR) from the median. Asterisks represent statistically
significant differences between two groups: **** p < 0.0001; (D) placental diameter determined by
ultrasound-based measurements comparing ED 11.5 and ED 14.5 (n = 31–39 placentas per group); data
are representative of at least two independent experiments; differences between individual groups were
analyzed by Mann–Whitney test. Error bars indicate the interquartile range (IQR) from the median.
Asterisks represent statistically significa t differences between two groups: **** p < 0.0001; (E–G) (De)
decidua, (BZ) basal zone, (LZ) labyrinth zo e, (CP) chorionic plate, and (YS) yolk sac. Histological
analysis of placental tissues following ZIKV infection; (E) Placentas were removed, nd sections of the
organs were routi ely stained with hematoxylin and eosin (HE) B r = 300 µm; (F) Sections of tissues
were treated ith von Kossa staining to identify tissue calcification Bar = 100 µm; black asterisks
indicate accumulations of dystrophic mineralization in the basal LZ of ZIKV-infected mice; (G) Placenta,
ED 16.5, immunohistochemic l st ining w th αZIKV. Variable, prominent intracytopl smic a tigen
expression in the chorionic ep thelium (black arrow), in spongiotrophoblasts and glycotrop oblasts
(inset) of the ZIKV-i fected gr up, whereas all placenta f the control group includ ng their horionic
epithelium (black arrow) were immun negative. Bar = 100 µm.
3.4. Macroscopic Outcome and Viral Burden
To more closely compare the results from USI to a standard characterization of ZIKV induced
pathogenesis in fetuses, we euthanized the mice on ED 16.5 and performed extensive necropsy.
In addition to the placental pathology we focused on the mortality, viral burden, and size of fetuses.
The data so far indicated that ZIKV infection invariably leads to fetal death or resorbed fetuses until
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ED 14.5–15.5. In line with these data, uteri obtained from ZIKV-infected dams did not contain any
viable fetuses (Figure 4A). As already visualized in USI between ED 13.5 and ED 16.5, ZIKV uteri
contained multiple foci of fetal residues with the respective placenta surrounding a mass of former fetal
tissue. In contrast, the uteri from mock PBS infected mothers contained multiple physiological fetuses
each including the specific placenta. Of note, the ZIKV induced mortality and pathogenesis came
along with massive inflammation resulting in resorption. This was seen by the presence of free liquids
indicative for inflammatory processes as early as ED 13.5 (Figure 4B). Interestingly, we confirmed
inflammation in necropsy on ED 16.5. When we characterized the structure of fetuses in more detail,
mean length of fetuses was significantly smaller in the ZIKV-infected group compared to the control
group (Figure 4D). Here, PBS control fetuses showed a mean size of 1,25 cm whereas the fetuses from
ZIKV-infected animals had a mean of 0.5 cm. Moreover, the fetuses from the ZIKV-infected dams
also showed significantly lower total weights with a mean of 0.11 g compared to 0.29 g in the viable
fetuses from the PBS control group (Figure 4E). To determine whether fetal damage goes along with
direct ZIKV infection in the fetus, we analyzed ZIKV infectious virus in fetal heads by plaques titration
(Figure 4C). We found large amounts of virus with a mean of 107 PFU/g tissue in the ZIKV group.
As expected, we failed to detect ZIKV in the PBS control group. To confirm productive infection in
the dams, we also detected ZIKV in the brain and spinal cord, the main target organs of the virus
(Figure 4F). Here, ZIKV-infected mice had high viral titers in the brain (107 PFU/g tissue) and the
spinal cord with a mean of 5 × 106 PFU/g tissue. In addition, we also evaluated the viral loads in the
ovaries and uteri to estimate the general impact of the infection on the reproductive tract (Figure 4F).
Interestingly, we detected lower amounts of ZIKV in these organs compared to brain and spinal cord,
with a mean of 104 PFU/g tissue for the uterus and a mean of 8 × 105 PFU/g tissue in the ovaries
indicating a placenta derived transmission of blood borne ZIKV to the fetuses.
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animals at the end of the experiment on ED 16.5; (B) Representative ultrasound image of a ZIKV-infected
uterus on ED 13.5 and the specific uterus of this ZIKV-infected animal on ED 16.5 at the end of the
experiment; white arrow indicates fluid-filled areas which were already detected in USI at ED 13.5 and
confirmed after necropsy; (C) Virus titers in the fetuses (fetal head) after ZIKV infection. At the end of
the experiments (ED 16.5) fetal heads were removed and homogenized, and the amount of virus was
determined by plaque assays (n = 31–39 per group); data are representative of at least two independent
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4. Discussion
ZIKV infection during pregnancy has been confirmed to lead to severe congenital malformations
and intrauterine death in human fetuses. During the 2015/2016 ZIKV epidemic, microcephaly was
the predominant symptom of congenital ZIKV infection in newborns. So far, there are no vaccines
or licensed therapeutics available. As a result, preclinical studies in mouse models of ZIKV infection
during pregnancy are essential to evaluate therapeutic and preventive measurements. A major hurdle
of such studies is to distinguish between ZIKV pathogenesis and immunopathology. Thus, we aimed
to establish a new diagnostic approach to directly and rapidly follow the infection in fetal IFNAR-/-
mice. In this study we established USI as imaging tool to evaluate ZIKV induced pathology in
fetal mice in vivo during pregnancy. Using USI in pregnant IFNAR-/- mice, we demonstrated fetal
gro th retardation and fetal death over time, indicating maternal-fetal transmission of ZIKV after
infection on ED 7.5. In pregnant omen, obstetric sonography is well established as safe diagnostic
tool with clinical utility, which is supported by umerous human case reports and epidemiologic l
studies. For ZIKV suspecte cases, CDC recommends repe ted diagnostic ultrasou d imaging (every
3–4 w eks) t evaluate fetal anatomy, particularly the head circumferences and the growth (https:
//www.cdc.gov/pregnancy/zika/testing-follow-up/prenatal-care.html). Howev r, obstetric sonography
is not comm nly used to examine pregnant mice du to th ir short gestation time nd the smaller
size. For some other experimental approaches e.g., brain development studies or evaluation on mouse
social behavior, USI on pregnant mice has been already used as valuable tool [42,43]. The overall
goal of our study was to contribute to the development of USI as for the monitoring of congenital
infections in mice. We chose ZIKV as a model pathogen, and to best of our knowledge USI has not
been tested as rapid diagnostic tool in a mouse model of ZIKV infection. Indeed, there are already
published studies characterizing murine models of congenital Zika virus syndrome with regard to
placental and fetal pathologies. Our objective was to analyze the course and outcome of ZIKV infection
in the IFNAR-/- mouse model. Different mouse models have been established as preclinical models
to better understand ZIKV induced pathogenesis. Thus, mouse models also offer the opportunity to
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study influence of ZIKV infection for the fetuses using pregnant mice. Of course, mice are different
from humans with regard to physiology and disease development. In detail, mice reveal a significantly
shorter gestation time and the placental layers are different compared to humans. However, mice
and humans both feature a hemochorial placenta [44,45]. From that aspect mouse studies might be
appropriate to evaluate pathogenesis and countermeasures of congenital pathogens. As established
by Miner et al. [30], ZIKV infection in pregnant IFNAR-/- mice results in a slightly different clinical
outcome compared to the human ZIKV pathogenesis, since the fetuses do not show microcephaly,
brain calcification and defects in brain development. However, this feature does not hamper the
definition of fetoprotective countermeasures in the IFNAR-/- pregnancy model. Miner et al. found a
profound pathological change in ZIKV-infected placentas. Here, the hypothesis is that ZIKV infects
the fetus through blood-placental transmission causing direct viral cytotoxicity. In addition, the fetus
is also damaged due to the destruction of the placenta resulting in severe ischemia [46]. For our
approach to study the effects of candidate vaccines or therapeutics to prevent ZIKV transmission to
the fetus, this model might be well-suited. In the context of USI characterization, the first step was
to visualize ZIKV induced changes in the fetus and in the placenta. Our results from daily USI of
pregnant ZIKV-infected and mock-infected pregnant mice demonstrated that first visible signs of
infection were observed on ED 13.5, which corresponds to the second trimester in human pregnancy.
This is in line with the results from case reports in humans. Here, after potential ZIKV infections during
pregnancy, ultra-sonographic examination also identified first signs of ZIKV pathogenesis in the second
trimester [17]. The leading symptom of ZIKV pathogenesis as evaluated in obstetric sonography was
the growth retardation. This was also confirmed in our USI-mouse model. The sonography allows
to specifically visualize fetal development and growth, as we were able to differentiate between the
respective fetuses and the corresponding body parts. For this, fetal USI in mice might also contribute
to other aspects of research questions involving pregnant mice. Of note, we did not detect distinct
fetal structural abnormalities in single body parts. Instead we observed significant fetal growth
retardation compared to the mock-infected fetuses. This obvious clinical parameter might allow to
rapidly confirm fetoprotective countermeasure also in other applications. In this first approach, we
did not observe significant modifications in the gross-morphological structure of the placentas from
ZIKV-infected dams. This is different from the human case reports, where placentas already revealed
visible calcification in the second trimester even though the placental thickness appeared normal [17].
Placenta pathology, e.g., calcifications, is likely more obvious in humans due to the comparatively
longer gestation time. Thus, the extent of the calcifications is more advanced and better visible by USI.
In addition, most of the human pregnancy comprises a single pregnancy. In contrast, mice harbor
multiple pregnancies including multiple placentas. Thus, the USI analysis is more difficult in mice.
Nevertheless, using histological methodology we could readily confirm mineralization of placental
tissue in mice. Thus, the ZIKV mouse model is still to be considered as an appropriate model to study
these pathological processes also due to the similar type of placentas (humans and mice both harbor
a hemochorial placenta). However, when we specifically monitored the placental anatomy in more
detail, the placenta thickness appeared to continuously decrease over the time starting about ED 11.5.
This shrinking indicates a ZIKV induced pathological conversion of the physiological placental tissue
in favor of calcifications. This has been already described in previous studies [47]. Here, placental
thinning as identified by echogenic foci correlated with calcification of the placenta. This is further
confirmed by the post-mortem analysis of the placentas confirming that the significantly lower weights
are a result of continued calcification. Placental calcification is an also common phenomenon in
physiological pregnancy at term and is regarded as a physiological aging process [48,49]. However,
earlier placental calcification could be considered as a direct cytotoxic effect of ZIKV infection. Indeed,
we detected significant amounts of ZIKV in placentas. This is in line with data from Hastings and
colleagues who analyzed the influence of TAM receptors for the transmission of ZIKV through the
transplacental route and replication of the virus in fetal tissues in the pregnant ZIKV mouse model [50].
Moreover, productive placental ZIKV infection, as visualized in USI, was further confirmed in gross
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morphological analysis. This is in line with the data from other preclinical ZIKV models. In pregnant
rhesus maquaces, Hirsch et al. [37] showed placental infarctions with large gross vascular obliteration
and villous stromal calcifications, which were a consequence of stromal fibroblast cell death. Another
outcome of our placental ZIKV infection model was a reduced uteroplacental blood flow activity,
which was measured using Doppler-USI. Interestingly, this observation appeared to be the most
obvious and earliest sign of ZIKV pathogenesis when evaluating the course of disease by USI. Of note,
the contribution of vascular restriction on fetal and placental growth on IUGR and decreasing cardiac
output has already been confirmed in human studies [51,52]. Since these alterations were already
visible as early as ED 12.5 in the fetuses, this will allow for the evaluation of fetoprotection with a
high sensitivity. In addition, using Doppler USI monitoring, as established in the ZIKV mouse model,
the identification of possible effects of immunopathogenesis in control mice will be possible. To date
we have a very limited understanding about the kinetics of immune responses during pregnancy.
For example, we have limited knowledge of the mechanisms of vaccine-induced protection for the
fetus after vaccination of the mother. This is also true for microbial defense during pregnancy. In this
context, the placenta is known to be an active immunological organ orchestrating innate immune
responses to protect the fetus by secretion of inflammatory cytokines. The type of reactivity initiated
by the placenta dictates the outcome of the immunological response for the fetus and the mother [53].
Thus, the availability of an imaging tool that allows for the classification of substances that are harmful
and not harmful to fetuses has the potential to be valuable for other applications. We used this imaging
tool to monitor blood flow activity in the fetal brain. Using this approach, we were able to detect visible
differences between the mock-infected and ZIKV-infected group. However, a real correlation was not
possible, as the profound effect of ZIKV infection on fetuses made it impossible to differentiate and
locate the fetal heads by USI. This is in line with previous studies from Miner et al. In the mouse model,
they did not detect ZIKV induced microcephaly as the major clinical outcome in newborn. This might
be due to neurodevelopmental differences during embryogenesis in mice and humans [30]. In addition,
our data indicate that ZIKV infection results in significant IUGR which in consequence probably
induces efficient fetal resorption. This hypothesis would also explain the absence of microcephaly in
the mouse model. In contrast, in the non-human primate model, ZIKV infection during pregnancy
results in microcephaly and brain defects [54]. Of note, the hypothesis of rapid fetal remission is
further supported by the findings of post-mortem evaluations. This has been confirmed in the uterus,
where we revealed free liquids in USI indicative for massive reactivity and reorganization due to
ZIKV induced pathogenesis. In summary, our USI based characterization of ZIKV disease in pregnant
IFNAR-/- revealed the suitability of this method to identify and correlate infection with pathogenesis.
This is because we could directly confirm the findings as evaluated during the course of infection
by USI with the results obtained after necropsy, which included viral titration and macroscopical
findings. In future studies it will be interesting to combine such models of congenital ZIKV infection
with USI and/or therapeutic countermeasures. Miner and Coyne used the pregnant mouse model to
comparatively evaluate congenital infection and placental and fetal pathology [55]. In the next step
they transferred the results from the mouse model to human placental explants. This approach will be
also appealing to study other infections in the pregnant mouse model using USI/ US Doppler as intra
vitam readout, e.g., other flaviviruses, murine cytomegalovirus, or toxoplasma gondii [56,57]. Future
work in this model will be particularly helpful to further analyze the influence of selected therapeutic
and preventive agents on the outcome of infection in fetuses and mothers.
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